Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 152684-26-9 | MDL No. : | MFCD00834963 |
Formula : | C6H5BrN2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OLWFTDPHNVYMMN-UHFFFAOYSA-N |
M.W : | 233.02 | Pubchem ID : | 817774 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 47.25 |
TPSA : | 67.94 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.53 cm/s |
Log Po/w (iLOGP) : | 1.5 |
Log Po/w (XLOGP3) : | 1.68 |
Log Po/w (WLOGP) : | 1.76 |
Log Po/w (MLOGP) : | 1.45 |
Log Po/w (SILICOS-IT) : | -0.09 |
Consensus Log Po/w : | 1.26 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.58 |
Solubility : | 0.611 mg/ml ; 0.00262 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.72 |
Solubility : | 0.443 mg/ml ; 0.0019 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.39 |
Solubility : | 0.943 mg/ml ; 0.00405 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.43 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | Stage #1: for 2.5 h; Stage #2: With sodium carbonate In water; ethyl acetate |
A 3-neck I -L flask was fitted with a heating mantle, temperature controller, and an overhead stirrer. To the reaction flask was added 2-nitro-3'"iethoxy-5-bromopyridine 2 (37.5 g 0.16 mol), acetic acid (600 ml), and iron powder ( 18.9 g, 0.34 mol), and the resulting mixture was stirred and heated at 80 0C for 2.5 h. The reaction was deemed complete by LCMS and allowed to cool to rt. The reaction mixture was filtered through Celite and the filter cake was washed with acetic acid, and the combined filtrate and washings were concentrated. The resulting residue was partitioned between saturated aqueous Na2CO3 solution (400 mi) and EtOAc (400 ml) and the layers separated. The organic phase was washed with brine (200 mL), dried (Na>=SC^), filtered, and concentrated to afford 32.5 g (0.16 mol, 99 percent yield) of a tan solid as 2-amino-3-methoxy-5- bromopyridine:1H NMR (300 MHz, DMSO^fe) δ pom 7.56 (d, ./= 2.1 Hz, 1 H), 7.17 (d, ./ = 2.1 Hz, 1 H), 5.93 (br s, 2 H), 3.79 (s, 3 H); LCMS m/s (MH+) 203.0, /R - 0.34 min. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With sulfuric acid; nitric acid In water at 0℃; for 20 h; | The compound (20.91 g, 0.11 mol) obtained in Step 1 was dissolved in concentrated sulfuric acid (63 ml), nitric acid (5.2 ml, 0.12 mol) was added under ice-cooling, and the mixture was stirred for 20 hr. The reaction mixture was gently poured into ice water and the mixture was stirred. The precipitated solid was filtered and washed with water. The obtained solid was dissolved in ethyl acetate, and the solution was washed with saturated aqueous sodium hydrogencarbonate solution and saturated brine, and dried over magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure to give the object product as a pale-yellow solid (21.97 g, yield 85percent). 1H NMR(CDCl3 400 MHz) (δ) ppm: 4.01 (3H, s), 7.68 (1H, d, J=1.6 Hz), 8.16 (1H, d, J=1.9 Hz) |
76% | Stage #1: at 20℃; Stage #2: at 0 - 20℃; Stage #3: With sodium carbonate In water; ethyl acetate |
To a cooled flask containing 3-methoxy-5-bromopyridine I (39,8 g, 0.21 mol) was slowly added concentrated H2SO4 (120 ml) with the reaction mixture temperature maintained below 20 °C. The resulting mixture was stirred unitl homogeneity. The reaction mixture was cooled to 0-5 ftC and 90percent I INO3 (16>;5 g, 0.24 moi) was added dropwise while maintaining constant temperature. The resulting reaction mixture was stirred for 24 h, at ambient temperature. The reaction was deemed complete (<;5percent of 1 by HPLC) and the reaction mixture was poured onto ice (400 g), then partitioned with EtOAc (400 ml). The layers were separated and (he organic phase was sequentially washed with saturated aqueous Na2CO3 solution (400 ml), water (400 ml) and brine (400 ml), dried overNa2SO-i) Tillered, and concentrated under reduced pressure to furnish a pale yellow solid (45.8 g) as crude product. The material was recrystallized from MTBE (175 mL) and the crystals were harvested, washed with cold MTBK (80 mL-), and dried under high vacuum to give 22.7 g of yellow soiM as product. The mother liquor and filtraie were combined, concentrated, and recrystoellized from MTBE (35 mL) gave 6.3 g of pure product, The remaining mother liquor and filtrates were combined and concentrated. The resulting residue was purified by silica gel chromatography, eluting with a slow gradient of hexanes-EtOAc (hexanes, 4:1 hexancs-EtOAc) to give 8.5 g of product, Λ combined total of 37.5 g (0.16 mol, 76percent yield) of a yellow crystalline solid was obtained as 2-nitro-3 -methoxy-5 -bromopyridine:1H NMR (30Q MHz, CDCl3) 6 8.16 (d, J.(TM). 1.9 Hz, 1 H), 7.68 (d, J = 1.6 Hz, 1 H), 4.01 (s, 3 H); IXMS m/z (MH') 232.9, /R 0.73 min. |
[ 42409-58-5 ]
5-Bromo-3-methoxypyridin-2-amine
Similarity: 0.81
[ 947249-16-3 ]
5-Bromo-3-methoxy-6-methylpyridin-2-amine
Similarity: 0.73
[ 42409-58-5 ]
5-Bromo-3-methoxypyridin-2-amine
Similarity: 0.81
[ 1616526-81-8 ]
6-Chloro-3-methoxy-2-nitropyridine
Similarity: 0.77
[ 947249-13-0 ]
5-Bromo-3-(difluoromethoxy)pyridin-2-amine
Similarity: 0.73
[ 947249-16-3 ]
5-Bromo-3-methoxy-6-methylpyridin-2-amine
Similarity: 0.73
[ 1616526-81-8 ]
6-Chloro-3-methoxy-2-nitropyridine
Similarity: 0.77
[ 15128-90-2 ]
3-Hydroxy-6-methyl-2-nitropyridine
Similarity: 0.76
[ 42409-58-5 ]
5-Bromo-3-methoxypyridin-2-amine
Similarity: 0.81
[ 1616526-81-8 ]
6-Chloro-3-methoxy-2-nitropyridine
Similarity: 0.77
[ 15128-90-2 ]
3-Hydroxy-6-methyl-2-nitropyridine
Similarity: 0.76